ID   YCC-22
AC   CVCL_9655
SY   YCC22
DR   cancercelllines; CVCL_9655
DR   GEO; GSM2267434
DR   Progenetix; CVCL_9655
DR   Wikidata; Q54995333
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 26 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
RX   PubMed=29435981; DOI=10.1002/ijc.31304;
RA   Kim H.J., Kang S.K., Kwon W.S., Kim T.S., Jeong I., Jeung H.-C.,
RA   Kragh M., Horak I.D., Chung H.C., Rha S.Y.;
RT   "Forty-nine gastric cancer cell lines with integrative genomic
RT   profiling for development of c-MET inhibitor.";
RL   Int. J. Cancer 143:151-159(2018).
//